Logo image of LHYFE.PA

LHYFE SAS (LHYFE.PA) Stock Fundamental Analysis

EPA:LHYFE - Euronext Paris - Matif - FR0014009YQ1 - Common Stock - Currency: EUR

3.2  -0.01 (-0.31%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to LHYFE. LHYFE was compared to 61 industry peers in the Oil, Gas & Consumable Fuels industry. LHYFE may be in some trouble as it scores bad on both profitability and health. LHYFE shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

LHYFE had negative earnings in the past year.
LHYFE had a negative operating cash flow in the past year.
LHYFE had negative earnings in each of the past 5 years.
In the past 5 years LHYFE always reported negative operating cash flow.
LHYFE.PA Yearly Net Income VS EBIT VS OCF VS FCFLHYFE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

The Return On Assets of LHYFE (-13.08%) is worse than 90.16% of its industry peers.
Looking at the Return On Equity, with a value of -40.50%, LHYFE is doing worse than 90.16% of the companies in the same industry.
Industry RankSector Rank
ROA -13.08%
ROE -40.5%
ROIC N/A
ROA(3y)-14.91%
ROA(5y)-15.02%
ROE(3y)-30.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LHYFE.PA Yearly ROA, ROE, ROICLHYFE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 -50 100

1.3 Margins

LHYFE's Gross Margin of 82.53% is amongst the best of the industry. LHYFE outperforms 88.52% of its industry peers.
In the last couple of years the Gross Margin of LHYFE has grown nicely.
The Profit Margin and Operating Margin are not available for LHYFE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 82.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y97.82%
GM growth 5YN/A
LHYFE.PA Yearly Profit, Operating, Gross MarginsLHYFE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K -40K -50K

More info and screens

2

2. Health

2.1 Basic Checks

LHYFE does not have a ROIC to compare to the WACC, probably because it is not profitable.
LHYFE has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, LHYFE has more shares outstanding
Compared to 1 year ago, LHYFE has a worse debt to assets ratio.
LHYFE.PA Yearly Shares OutstandingLHYFE.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
LHYFE.PA Yearly Total Debt VS Total AssetsLHYFE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

LHYFE has an Altman-Z score of -0.14. This is a bad value and indicates that LHYFE is not financially healthy and even has some risk of bankruptcy.
LHYFE has a worse Altman-Z score (-0.14) than 85.25% of its industry peers.
LHYFE has a Debt/Equity ratio of 0.97. This is a neutral value indicating LHYFE is somewhat dependend on debt financing.
The Debt to Equity ratio of LHYFE (0.97) is worse than 73.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Altman-Z -0.14
ROIC/WACCN/A
WACC7.51%
LHYFE.PA Yearly LT Debt VS Equity VS FCFLHYFE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

LHYFE has a Current Ratio of 1.86. This is a normal value and indicates that LHYFE is financially healthy and should not expect problems in meeting its short term obligations.
LHYFE has a Current ratio of 1.86. This is in the better half of the industry: LHYFE outperforms 62.30% of its industry peers.
A Quick Ratio of 1.86 indicates that LHYFE should not have too much problems paying its short term obligations.
LHYFE's Quick ratio of 1.86 is fine compared to the rest of the industry. LHYFE outperforms 73.77% of its industry peers.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 1.86
LHYFE.PA Yearly Current Assets VS Current LiabilitesLHYFE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M

More info and screens

7

3. Growth

3.1 Past

LHYFE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.12%, which is quite good.
Looking at the last year, LHYFE shows a very strong growth in Revenue. The Revenue has grown by 287.17%.
Measured over the past years, LHYFE shows a very strong growth in Revenue. The Revenue has been growing by 195.81% on average per year.
EPS 1Y (TTM)13.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.06%
Revenue 1Y (TTM)287.17%
Revenue growth 3Y195.81%
Revenue growth 5YN/A
Sales Q2Q%268.49%

3.2 Future

Based on estimates for the next years, LHYFE will show a very strong growth in Earnings Per Share. The EPS will grow by 27.21% on average per year.
The Revenue is expected to grow by 129.95% on average over the next years. This is a very strong growth
EPS Next Y0.52%
EPS Next 2Y30.4%
EPS Next 3Y27.21%
EPS Next 5YN/A
Revenue Next Year347.89%
Revenue Next 2Y329.32%
Revenue Next 3Y207.51%
Revenue Next 5Y129.95%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LHYFE.PA Yearly Revenue VS EstimatesLHYFE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
LHYFE.PA Yearly EPS VS EstimatesLHYFE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

LHYFE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LHYFE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LHYFE.PA Price Earnings VS Forward Price EarningsLHYFE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LHYFE.PA Per share dataLHYFE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as LHYFE's earnings are expected to grow with 27.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.4%
EPS Next 3Y27.21%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LHYFE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LHYFE SAS

EPA:LHYFE (8/11/2025, 7:00:00 PM)

3.2

-0.01 (-0.31%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)03-27 2025-03-27/amc
Earnings (Next)N/A N/A
Inst Owners9.23%
Inst Owner ChangeN/A
Ins Owners3.29%
Ins Owner ChangeN/A
Market Cap153.50M
Analysts83.64
Price Target5.2 (62.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.39%
PT rev (3m)0.39%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.55%
Revenue NY rev (3m)-1.55%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 30.1
P/FCF N/A
P/OCF N/A
P/B 2.14
P/tB 2.86
EV/EBITDA N/A
EPS(TTM)-0.61
EYN/A
EPS(NY)-0.79
Fwd EYN/A
FCF(TTM)-1.29
FCFYN/A
OCF(TTM)-0.56
OCFYN/A
SpS0.11
BVpS1.5
TBVpS1.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.08%
ROE -40.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 82.53%
FCFM N/A
ROA(3y)-14.91%
ROA(5y)-15.02%
ROE(3y)-30.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y97.82%
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 745.26%
Cap/Sales 687.82%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.86
Quick Ratio 1.86
Altman-Z -0.14
F-Score5
WACC7.51%
ROIC/WACCN/A
Cap/Depr(3y)957.78%
Cap/Depr(5y)2682.27%
Cap/Sales(3y)1925.18%
Cap/Sales(5y)13341.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.06%
EPS Next Y0.52%
EPS Next 2Y30.4%
EPS Next 3Y27.21%
EPS Next 5YN/A
Revenue 1Y (TTM)287.17%
Revenue growth 3Y195.81%
Revenue growth 5YN/A
Sales Q2Q%268.49%
Revenue Next Year347.89%
Revenue Next 2Y329.32%
Revenue Next 3Y207.51%
Revenue Next 5Y129.95%
EBIT growth 1Y15.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year31.74%
EBIT Next 3Y36.05%
EBIT Next 5Y27.12%
FCF growth 1Y1.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.3%
OCF growth 3YN/A
OCF growth 5YN/A